Sumary of Frailty contributes to neurocognitive decline in young adult childhood cancer survivors:
- Jude Children’s Research Hospital have found a link between post-cancer treatment frailty and neurocognitive decline in young adult childhood cancer survivors.
- Though frailty is often associated with the elderly, 8% of young adult childhood cancer survivors meet the criteria for frailty.
- This study confirms that those who undergo childhood cancer treatment can experience frailty, which can create an early onset of neurocognitive decline in young adults.
- This study will help with further research to prevent such neurocognitive decline.
- “We think this is going to put more attention on this accelerated aging phenotype in young adult survivors,” said first author AnnaLynn Williams, Ph.
- “It’s going to make it a bit easier for us to identify the survivors most at risk for neurocognitive decline.
- “We can use this information, and the rest of our frailty research, to design a broad intervention that might simultaneously help us improve frailty in survivors as well as neurocognitive functioning,” Williams said.
- More important than previously recognized Cancer-related neurocognitive impairment is present in up to 35% of childhood cancer survivors.